ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

OP

Orion Pharma at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Orion Pharma takes part in 2 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1047. Its research focuses on experimental cancer treatments across solid tumours. The studies assess a dual-target antibody in mouse tumour models and evaluate ODM-212 in human cancers.

OrganizationESMO 2026 Attendance
OP
Orion Pharma
Large pharmaExhibitor
Finnish pharmaceutical company that co-developed the prostate cancer drug darolutamide with Bayer.
Booth
Exhibiting at Booth 1047
Poster
Fri Oct 23
15:15–16:00

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Orion Pharma

Tell us what you sell and we’ll find the people at Orion Pharma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction